Intrauterine fetal death and delivery complications associated with coagulopathy: A retrospective analysis of 104 cases

Journal of Women's Health

Volumn 18, Issue 4, 2009, Pages 469-474

  Tempfer, Clemens B ^a   Brunner, Andreas ^b   Bentz, Eva Katrin ^a   Langer, Martin ^a   Reinthaller, Alexander ^a   Hefler, Lukas A ^a  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b Moedling Community Hospital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; COHORT ANALYSIS; DELIVERY; FEMALE; FETUS DEATH; HELLP SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; UTERUS RUPTURE;

ADULT; BLOOD COAGULATION DISORDERS; COHORT STUDIES; FEMALE; FETAL DEATH; FETAL MEMBRANES, PREMATURE RUPTURE; HELLP SYNDROME; HUMANS; OBSTETRIC LABOR COMPLICATIONS; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 64749102433     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.0938     Document Type: Article

References (25)

1. Martinelli E, Taioli I, Cetin E. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343;1015-1018.
2. Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol 2003;189:861-873.
3. Hamilton BE, Minino AM, Martin JA, Knochanek KD, Strobino DM, Guyer B. Annual summary of vital statistics: 2005. Pedriatics 2007;119:346-360.
4. Silver RM, Varner MW, Reddy U, et al. Work-up of stillbirth: A review of the evidence. Am J Obstet Gynecol 2007;196: 433-444.
5. Stirrat GM. Recurrant miscarriage. Lancet 1990;336:673-675.
6. Samueloff A, Xenakis EM, Berkus MD, Huff RW, Langer O. Recurrent stillbirth. Significance and characteristics. J Re-prod Med 1993;38:883-886.
7. Gris JC, Quere I, Monpeyroux F, et al. Case controlled study of the frequency of thombophilic disorders in couples with late fetal loss and no thrombotic antecedent-The Nimes Obstetricans and Haematolgists Study 5 (NOHA5). Thromb Haemost 1999;81:891-899.
8. Weiner AE, Reid D, Roby C, Diamond LK. Coagulation defects with intrauterine death from Rh isoimmunization. Am J Obstet Gynecol 1950;60:1015-1018.
9. Pritchard JA, Ratnoff OD. Fetal death in utero. Obstet Gy-necol 1959;14:573-580.
10. Goldstein DP, Reid DE. Circulating fibrinolytic activity: A precursor of hypofibrinogenemia following fetal death in utero. Obstet Gynecol 1963;22:174-181.
11. Lerner R, Margolin M, Slate WG. Heparin in the treatment of hypofibrinogenemia complicating fetal death in utero. Am J Obstet Gynecol 1967;97:373-381.
12. Jimenez JM, Pritchard JA. Pathogenesis and treatment of coagulation defects resulting from fetal death. Obstet Gy-necol 1968;32:449-455.
13. Diagnosis and management of fetal death. ACOG Technical Bulletin Number 176. Int J Gynaecol Obstet 1993;42:291-299.
14. 2 tablets compared with intravenous oxytocin in induction of labour. BMJ 1975;1:14-26.
15. Maslow AD, Breen TW, Sarna MC, Soni AK, Watkins J, Oriol NE. Prevalence of coagulation abnormalities associated with intrauterine fetal death. Can J Anaesth 1996;43: 1237-1243.
16. Dekker JW, Lind J, Bloemenkamp KW, et al. Inherited risk of thrombosis of the fetus and intrauterine fetal death. Eur J Obstet Gynecol Reprod Biol 2004;117:45-48.
17. Simon L, Santi TM, Sacquin P, Hamza J. Pre-anaestetic assessment of coagulation abnormalities in obstetric patients: Usefulness, timing and clinical implications. Br J Anaesth 1997;78:678-683.
18. Magann EF, Hauhan SP, Bofil JA, Waddell D, Rust OA, Morrison JC. Maternal morbidity and mortality associated with intrauterine fetal demise: Five year experience in a tertiary referral hospital. South Med J 2001;94: 493-495.
19. Barron WM, Heckerling P, Hibbard JU, Fisher S. Reducing unnecessary coagulation testing in hytertensive disorders of pregnancy. Obstet Gynecol 1999;94:364-370.
20. Metz J, Cincotta R, Francis M, DeRosa L, Balloch A. Screening for consumptive coagulopathy in preeclampsia. Int J Gynecol Obstet 1994;46:3-9.
21. Hatch RL, Barke JI, Barke MW. Coagulopathy associated with dilatation and evacuation for intrauterine death. Obstet Gynecol 1985;66:463-467.
22. Strauss JH, Ballard JO, Chmlian D. Consumption coagulo-pathy associated with intrauterine fetal death: The role of heparin therapy. Int J Gynecol Obstet 1978;16:225-227.
23. Statistik Austria, National Health Report 2004. www.statistik .at Accessed December 20, 2007.
24. Sharma PP, Salihu HM, Qyelese Y, Ananth CV, Kirby RS. Is race a determinant of stillbirth recurrence? Obstet Gynecol 2006;107:391-397.
25. Vintzileos AM, Ananth CV, Smulian JC, Scorza WE, Knup-pel RA. Prenatal care and black-white fetal death disparity in the United States: Heterogeneity by high-risk conditions. Obstet Gynecol 2002;99:483-489.